참고문헌
- Siegel RL, Miller KD and Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68, 277-300
- Coudray N, Moreira AL, Sakellaropoulos T, Fenyo D, Razavian N and Tsirigos A (2018) Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med 24, 1559-1567 https://doi.org/10.1038/s41591-018-0177-5
- Yamasaki T, Nakazaki Y, Yoshida M and Watanabe Y (2011) Roles of conserved arginines in ATP-binding domains of AAA+ chaperone ClpB from Thermus thermophiles. FEBS J 278, 2395-2403 https://doi.org/10.1111/j.1742-4658.2011.08167.x
- Nouet C, Truan G, Mathieu L and Dujardin G (2009) Functional analysis of yeast bcs1 mutants highlights the role of Bcs1p-specific amino acids in the AAA domain. J Mol Biol 388, 252-261 https://doi.org/10.1016/j.jmb.2009.03.018
- Zheng L, Li T, Zhang Y et al (2015) Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer. Oncol Rep 33, 2337-2344 https://doi.org/10.3892/or.2015.3867
- Fouret R, Laffaire J, Hofman P et al (2012) A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma. Clin Cancer Res 18, 5606-5616 https://doi.org/10.1158/1078-0432.CCR-12-0505
- Alvarez JV, Belka GK, Pan T et al (2014) Oncogene pathway activation in mammary tumors dictates [18F]-FDG-PET uptake. Cancer Res 74, 7583-7598 https://doi.org/10.1158/0008-5472.CAN-14-1235
- Zou JX, Revenko AS, Li LB, Gemo AT and Chen HW (2007) ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. Proc Natl Acad Sci U S A 104, 18067-18072 https://doi.org/10.1073/pnas.0705814104
- Zhang Y, Sun Y, Li Y et al (2013) ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma. Ann Surg Oncol 20, 577-582 https://doi.org/10.1245/s10434-013-3027-1
- Fan Y, Dickman KG, Zong WX (2010) Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J Biol Chem 285, 7324-7333 https://doi.org/10.1074/jbc.M109.035584
- Caron C, Lestrat C, Marsal S et al (2010) Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene 29, 5171-5181 https://doi.org/10.1038/onc.2010.259
- Wu G, Liu H, He H et al (2014) miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis. BMC Cancer 14, 1-11 https://doi.org/10.1186/1471-2407-14-1
- Wan WN, Zhang YX, Wang XM et al (2014) ATAD2 is highly expressed in ovarian carcinomas and indicates poor prognosis. APJCP 15, 2777-2783
- Shang P, Meng FL, Liu YD and Chen XW (2015) Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis. Tumor Biol 36, 4479-4485 https://doi.org/10.1007/s13277-015-3089-8
- Zhang MJ, Zhang CZ, Du WJ, Yang XZ and Chen ZP (2015) ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker. Clin Transl Oncol 18, 1-6 https://doi.org/10.1007/s12094-015-1332-9
- Jadvar H, Alavi A, Gambhir SS (2009) [18F]FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med 50, 1820-1827 https://doi.org/10.2967/jnumed.108.054098
- Cho H, Lee YS, Kim J, Chung JY and Kim JH (2013) Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. Cancer Invest 31, 607-615 https://doi.org/10.3109/07357907.2013.849722
- Chae YC and Kim JH (2018) Cancer stem cell metabolism: target for cancer therapy. BMB Rep 51, 319-326 https://doi.org/10.5483/BMBRep.2018.51.7.112
- Zhuo B, Li Y, Li Z et al (2015) PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma. Biochem Biophys Res Commun 464, 401-406 https://doi.org/10.1016/j.bbrc.2015.06.092
- Wang H, Wang L, Zhang YJ, Wang J, Deng YB and Lin DG (2016) Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int 16, 9 https://doi.org/10.1186/s12935-016-0280-y
- Boussouar F, Jamshidikia M, Morozumi Y, Rousseaux S and Khochbin S (2013) Malignant genome reprogramming by ATAD2. Biochim Biophys Acta 1829, 1010-1014 https://doi.org/10.1016/j.bbagrm.2013.06.003
- Wu K, Wang W, Chen H, Gao W and Yu C (2019) Insulin promotes proliferation of pancreatic ductal epithelial cells by increasing expression of PLK1 through PI3K/AKT and NF-kB pathway. Biochem Biophys Res Commun 509, 925-930 https://doi.org/10.1016/j.bbrc.2018.12.182
- Tsai JS, Chao CH and Lin LY (2016) Cadmium activates multiple signaling pathways that coordinately stimulate Akt activity to enhance c-Myc mRNA stability. PLoS One 11, e0147011 https://doi.org/10.1371/journal.pone.0147011
- Hong SY, Yu FX, Luo Y and Hagen T (2016) Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. Cell Signal 28, 377-383 https://doi.org/10.1016/j.cellsig.2016.01.011
- Stine ZE, Walton ZE, Altman BJ, Hsieh AL and Dang CV (2015) MYC, metabolism, and cancer. Cancer Discov 5, 1024-1039 https://doi.org/10.1158/2159-8290.CD-15-0507
- Wahlstrom T and Henriksson MA (2015) Impact of MYC in regulation of tumor cell metabolism. Biochim Biophys Acta 1849, 563-569 https://doi.org/10.1016/j.bbagrm.2014.07.004
- Ciro M, Prosperini E, Quarto M et al (2009) ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Res 69, 8491-8498 https://doi.org/10.1158/0008-5472.CAN-09-2131